Cars.com
CARS
Lantheus
LNTH
Halozyme Therapeutics
HALO
DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
Collegium Pharmaceutical
COLL
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 1.15%10.13B | 3.73%2.55B | 0.05%2.52B | 4.64%2.9B | 2.42%2.83B | 3.80%10.01B | 49.83%2.46B | -5.63%2.52B | 3.64%2.77B | 4.02%2.77B |
Operating revenue | 1.15%10.13B | 3.73%2.55B | 0.05%2.52B | 4.64%2.9B | 2.42%2.83B | 3.80%10.01B | 49.83%2.46B | -5.63%2.52B | 3.64%2.77B | 4.02%2.77B |
Cost of revenue | 0.50%2.57B | 2.94%654.4M | 2.16%651.8M | -0.65%821.9M | -2.21%788.3M | -0.30%2.56B | 475.82%635.7M | -23.73%638M | 0.53%827.3M | 0.84%806.1M |
Gross profit | 1.37%7.55B | 4.00%1.89B | -0.67%1.87B | 6.89%2.08B | 4.32%2.05B | 5.29%7.45B | 19.07%1.82B | 2.62%1.88B | 5.02%1.94B | 5.38%1.96B |
Operating expense | -24.63%2.95B | -8.75%726.6M | -24.62%731.3M | -25.83%794.1M | -31.74%809.2M | -5.77%3.91B | 3.89%796.3M | -17.93%970.1M | 0.15%1.07B | 4.38%1.19B |
Selling and administrative expenses | -1.33%933.4M | -0.86%243.1M | 3.36%227.7M | -4.13%234.3M | -2.61%257M | 4.87%946M | 59.12%245.2M | -4.71%220.3M | 9.65%244.4M | -10.21%263.9M |
Depreciation amortization depletion | -30.72%2.03B | -30.90%500.9M | -31.07%498.5M | -26.54%561.7M | -30.81%549.4M | -7.47%2.93B | 16.08%724.9M | -19.47%723.2M | -7.49%764.6M | -2.66%794.1M |
-Depreciation and amortization | -30.72%2.03B | -30.90%500.9M | -31.07%498.5M | -26.54%561.7M | -30.81%549.4M | -7.47%2.93B | 16.08%724.9M | -19.47%723.2M | -7.49%764.6M | -2.66%794.1M |
Other operating expenses | -131.47%-12.4M | 89.99%-17.4M | -80.83%5.1M | -103.08%-1.9M | -97.80%2.8M | -54.45%39.4M | -1,336.36%-173.8M | -49.62%26.6M | 213.20%61.7M | 388.51%127.5M |
Operating profit | 30.15%4.6B | 13.91%1.17B | 24.78%1.14B | 47.00%1.28B | 59.44%1.24B | 21.01%3.54B | 34.33%1.02B | 39.84%913M | 11.68%873.7M | 6.96%775.6M |
Net non-operating interest income expense | 0.02%-1.27B | 7.93%-289.1M | 1.27%-319.1M | -1.32%-321.7M | -3.01%-318.7M | -16.81%-1.27B | -5.76%-314M | -17.44%-323.2M | -21.04%-317.5M | -22.53%-309.4M |
Non-operating interest income | 14.00%135.2M | -4.46%32.1M | 13.21%37.7M | 42.81%43.7M | 55.84%48M | 141.55%118.6M | 450.82%33.6M | 77.13%33.3M | 113.99%30.6M | 211.11%30.8M |
Non-operating interest expense | 1.17%1.4B | -7.59%321.2M | 0.08%356.8M | 4.97%365.4M | 7.79%366.7M | 22.20%1.39B | 14.72%347.6M | 21.26%356.5M | 25.85%348.1M | 29.65%340.2M |
Other net income (expense) | 139.45%291.1M | 154.97%428.2M | -214.97%-269.6M | 180.74%65.8M | 215.54%113M | -394.92%-737.9M | 9.30%-778.9M | -50.95%234.5M | -121.54%-81.5M | -138.72%-97.8M |
Gain on sale of security | 193.25%308.3M | 242.89%539.7M | -241.17%-337.4M | 79.83%-21.7M | ---- | -173.24%-330.6M | 42.76%-377.7M | -49.63%239M | ---107.6M | ---- |
Special income (charges) | 78.98%-86.5M | 78.97%-86.5M | --0 | --0 | ---- | -123.09%-411.6M | -123.41%-411.3M | --0 | ---300K | ---- |
-Less:Impairment of capital assets | -75.50%68.6M | ---- | ---- | ---- | ---- | 90.09%280M | ---- | ---- | ---- | ---- |
-Less:Other special charges | ---- | ---- | ---- | ---- | ---- | -25.00%300K | --0 | ---- | --300K | ---- |
-Gain on sale of property,plant,equipment | 86.37%-17.9M | ---- | ---- | ---- | ---- | -256.79%-131.3M | ---- | ---- | ---- | ---- |
Other non- operating income (expenses) | 1,511.63%69.3M | -347.52%-25M | 1,606.67%67.8M | 231.44%87.5M | 215.54%113M | 125.75%4.3M | 168.24%10.1M | -212.50%-4.5M | -93.02%26.4M | -138.72%-97.8M |
Income before tax | 137.02%3.62B | 1,997.82%1.31B | -33.22%550.5M | 116.64%1.03B | 179.83%1.03B | -26.69%1.53B | 82.51%-68.8M | -3.68%824.3M | -47.16%474.7M | -49.20%368.4M |
Income tax | 303.41%366.3M | 1,089.47%75.2M | 147.27%122.4M | 809.09%120M | 104.49%109.2M | -19.50%90.8M | -116.24%-7.6M | 37.12%49.5M | 78.38%13.2M | 137.33%53.4M |
Net income | 66.79%2.28B | 9,151.88%1.23B | -235.18%-780.4M | 96.84%908.4M | 192.60%921.7M | -19.43%1.37B | 101.86%13.3M | -29.57%577.3M | -48.20%461.5M | -55.17%315M |
Net income continuous Operations | 126.52%3.26B | 2,110.62%1.23B | -44.75%428.1M | 96.84%908.4M | 192.60%921.7M | -27.10%1.44B | 86.09%-61.2M | -5.48%774.8M | -48.20%461.5M | -55.17%315M |
Net income discontinuous operations | -1,270.17%-978.3M | --0 | -511.90%-1.21B | ---- | ---- | 74.18%-71.4M | --74.5M | ---197.5M | ---- | ---- |
Minority interest income | 121.69%25.2M | 101.26%900K | 223.96%11.9M | 157.04%8.1M | 120.67%4.3M | -68.16%-116.2M | -118.29%-71.6M | 52.00%-9.6M | -94.52%-14.2M | -131.11%-20.8M |
Net income attributable to the parent company | 52.03%2.26B | 1,348.29%1.23B | -235.00%-792.3M | 89.26%900.3M | 173.20%917.4M | -16.00%1.48B | 112.42%84.9M | -30.11%586.9M | -47.04%475.7M | -52.82%335.8M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | 52.03%2.26B | 1,348.29%1.23B | -235.00%-792.3M | 89.26%900.3M | 173.20%917.4M | -16.00%1.48B | 112.42%84.9M | -30.11%586.9M | -47.04%475.7M | -52.82%335.8M |
Basic earnings per share | 51.89%4.83 | 1,361.11%2.63 | -234.92%-1.7 | 89.22%1.93 | 173.61%1.97 | -16.97%3.18 | 112.24%0.18 | -30.00%1.26 | -47.96%1.02 | -53.85%0.72 |
Diluted earnings per share | 51.57%4.82 | 1,355.56%2.62 | -234.92%-1.7 | 88.24%1.92 | 172.22%1.96 | -16.75%3.18 | 112.24%0.18 | -30.00%1.26 | -47.69%1.02 | -53.85%0.72 |
Dividend per share | 72.21%8.18 | 100.00%3.24 | 1.62 | 3.18%1.62 | 8.97%1.7 | -18.94%4.75 | 3.85%1.62 | 0 | 9.79%1.57 | 11.43%1.56 |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |